Can Steroids Cause Uncontrollable Shaking? Mechanisms, Timeline, and Tremor Types

Yes, steroids can cause uncontrollable shaking, though the shaking is almost always an action or postural tremor rather than the resting tremor of Parkinson's disease. Glucocorticoids such as prednisone amplify the body's normal physiologic tremor by raising catecholamine tone and upregulating beta-2 adrenergic receptors on muscle. The result is a fine, fast 6-12 Hz shake that appears in the hands when holding a cup or writing. It is dose related, most often reported above 20 mg/day of prednisone, and typically fades within weeks of tapering. It is rarely dangerous on its own but can signal electrolyte or glucose problems.

The Mechanism: How Steroids Amplify Physiologic Tremor

Every healthy person has a physiologic tremor. It oscillates at 6 to 12 Hz, and its amplitude is normally too small to see with the naked eye. The oscillation comes from a mechanical resonance of the hand and forearm combined with a central neural oscillator. Circulating catecholamines amplify it by acting on beta-2 adrenergic receptors in skeletal muscle fibers and muscle spindles. More epinephrine means more amplification, and a bigger visible shake.

Glucocorticoids raise that catecholamine signal through two separate routes. First, they induce the enzyme phenylethanolamine N-methyltransferase in the adrenal medulla, which converts norepinephrine into epinephrine. Second, they upregulate beta-2 receptor density on lymphocytes and other tissues, a classic permissive effect in which the steroid does not act directly but makes the tissue respond more strongly to adrenaline. The two effects converge on the same endpoint: a sensitized periphery where an ordinary adrenaline surge produces an extraordinary shake.

This is the counterintuitive part. Steroids do not build a tremor generator in the brain. They turn up the gain on a circuit that already exists in every healthy hand. That explains why steroid tremor vanishes at rest and why a tremor that persists at rest should send you looking for a different diagnosis entirely. In plain terms: steroids do not create new shaking, they make the shaking you already have louder.

A second, mineralocorticoid pathway matters at high doses. Prednisone and fludrocortisone promote salt and water retention, and the resulting hypokalemia below roughly 3.0 mEq/L can add tremor, cramping, and weakness. This is why a basic metabolic panel belongs in the workup of any new shake on steroids.

Dose Response: How Much Steroid Produces Shaking

Tremor is most consistently reported above 20 mg/day of prednisone, though published case reports exist at 7.5 mg/day and even lower in sensitive patients. The threshold is not sharp because it depends on receptor density, baseline anxiety, caffeine intake, and sleep debt. Pulse therapy with intravenous methylprednisolone at 250 to 1,000 mg/day can produce visible tremor within 24 to 72 hours, well before any oral equivalent would.

Dose equivalence matters when comparing reports. Dexamethasone 0.75 mg is roughly equivalent to prednisone 5 mg, so a dexamethasone dose of 6 mg/day is approximately prednisone 40 mg/day. A patient shaking on 6 mg of dexamethasone and a patient shaking on 40 mg of prednisone are describing the same glucocorticoid exposure. Without that conversion, dose comparisons across case reports become meaningless.

The best-known dose-response curve in this field comes from the Boston Collaborative Drug Surveillance Program in 1972, which found major psychiatric reactions in 1.3 percent of patients receiving 40 mg/day of prednisone or less, 4.6 percent at 41 to 80 mg/day, and 12.6 percent above 80 mg/day. The 40 mg and 80 mg cut points in that study describe psychiatric events, not tremor; the tremor threshold sits lower and is less sharp. Still, the shape of the curve is instructive. Neurologic sensitivity to glucocorticoids scales upward with dose rather than appearing at a single cliff edge.

Tremor Types and Look-Alike Causes

Steroid tremor is a postural and action tremor. It appears when the arms are held outstretched, when a cup is lifted, and when a signature is written. It is usually symmetric, affects the hands most obviously, and spares the head. Head tremor is not a typical steroid effect and points toward essential tremor, dystonia, or a medication reaction of a different kind.

The shake is involuntary but only partially uncontrollable. Patients can briefly suppress it by bracing the wrist or resting the arm against the body. A shake that cannot be suppressed for even a second, or that worsens dramatically with distraction, deserves a neurological examination.

Frequency alone cannot separate steroid tremor from its mimics. The 6 to 12 Hz band overlaps with essential tremor's 4 to 12 Hz range and with anxiety-related tremor, so context and timing do the diagnostic work rather than the oscillation rate itself.

Timeline: When Shaking Starts and Stops

For oral therapy, tremor usually appears 7 to 14 days after a high dose begins, not on day one. That delay fits the mechanism: receptor upregulation and adrenal enzyme induction take time to accumulate. Pulse intravenous therapy collapses that timeline to roughly 24 to 72 hours. Resolution follows the mirror image of onset, with improvement within a week of the first meaningful dose reduction and full clearance over 2 to 6 weeks after the steroid stops.

One practical consequence of this timeline: a shake that starts the same afternoon as the first 5 mg tablet is probably not the steroid. A shake that starts 10 days into a 40 mg course is a much better fit.

Edge Cases: Inhalers, Injections, Anabolic Steroids, Withdrawal

Inhaled corticosteroids are almost never the cause of shaking in asthma patients, even though patients assume they are. The tremor in that scenario usually comes from the co-prescribed beta-2 agonist, and albuterol produces fine tremor in roughly 10 to 25 percent of people who start it. Blaming the steroid in a combination inhaler is one of the most common attribution errors in respiratory medicine. Inhaled corticosteroid doses are far too low to produce the systemic receptor effects described above.

Local injections behave differently again. Epidural and intra-articular steroid injections deliver much lower systemic exposure than oral therapy, and tremor after them is uncommon and usually brief. When it does occur, it tends to follow a facial flush and a transient rise in blood glucose, both signs of systemic absorption.

Anabolic-androgenic steroids are a separate drug class and not a classic cause of tremor. Their documented harms run through blood pressure, lipids, and the cardiovascular system rather than the beta-adrenergic axis. Shaking reported by people using them is more often tied to co-used stimulants, heavy alcohol intake, or withdrawal, and it deserves the same differential workup as any other tremor. Assuming the anabolic steroid is responsible can hide a genuinely treatable cause.

Withdrawal is the edge case that matters most clinically. Abruptly stopping long-term glucocorticoids can precipitate adrenal insufficiency, which produces tremor, nausea, dizziness, and low blood pressure. Sodium under 130 mEq/L with potassium above 5.0 mEq/L and glucose under 60 mg/dL in a patient who recently stopped steroids is a medical emergency, not a dose-adjustment problem. Per the Endocrine Society's 2016 guidance on adrenal insufficiency, patients on prolonged glucocorticoid therapy require a structured taper rather than a sudden stop.

Red Flags and What to Actually Do

Most steroid tremor is benign and self-limited. Some presentations are not, and the following features should prompt urgent evaluation rather than a dose tweak.

• A resting tremor that is worse on one side, especially with slowed movement or stiffness, suggesting a parkinsonian syndrome rather than a drug effect.
• Tremor with fever, confusion, dark urine, or profound weakness, which can indicate adrenal crisis after a missed or stopped dose.
• Tremor with sweating, palpitations, and a glucose reading below 70 mg/dL, which needs glucose, not a steroid adjustment.
• Sudden tremor with facial droop, slurred speech, or one-sided weakness, which is a stroke evaluation until proven otherwise.
• Tremor with potassium under 3.0 mEq/L or sodium under 125 mEq/L, requiring electrolyte correction.
• Tremor that continues unchanged for more than 8 weeks after the steroid has been fully stopped, which points elsewhere.

For the ordinary case, the actions are straightforward and mostly non-pharmacologic. Do not stop the steroid on your own, because the taper protects the adrenal axis and a cold stop can cause more harm than the tremor. Record the dose, the clock time of each dose, caffeine intake, and sleep hours for two weeks, since patterns in that log often identify a modifiable trigger. Ask your prescriber whether a 10 to 25 percent dose reduction, a switch to a steroid-sparing agent, or a different dosing time is reasonable. Cut caffeine below roughly 200 mg per day, protect seven to eight hours of sleep, and eat regular meals to keep glucose stable.

If the tremor interferes with eating or writing, a clinician may offer propranolol at 10 to 40 mg as needed, the same approach used for enhanced physiologic tremor generally. Two cautions apply: nonselective beta blockers can worsen bronchospasm in asthma, and they can mask the warning signs of hypoglycemia in patients with diabetes. Simple physical tricks help more than people expect, including resting the forearm on a surface, using a heavier cup, and writing with the wrist stabilized rather than the fingers alone.

Limitations of the Evidence

Almost everything linking steroids to tremor comes from case reports, spontaneous adverse-event reporting, and secondary endpoints in trials designed for other outcomes. There is no randomized trial with accelerometry as a primary endpoint, and the true incidence is unknown because mild tremor is underreported by patients and under-recorded by clinicians. Per the FDA's prescribing information for prednisone, tremor appears among reported adverse reactions without a reliable frequency estimate.

Confounding is heavy in every direction. Patients on high-dose steroids are often simultaneously on beta-2 agonists, sleeping badly, drinking more coffee, and coping with a flare of a disease that itself causes fatigue and shakiness. Teasing the steroid contribution apart in a single patient is often impossible, and a trial of dose reduction is the most practical causality test available. Frequency bands overlap enough that no oscillation measurement can definitively attribute a tremor to a drug. The honest position is that steroid tremor is real, mechanistically plausible, dose related, and usually reversible, but individual attribution remains a clinical judgment rather than a laboratory result.